StockWatch
·
MAHANAGAR GAS · Q2 FY27 · THE VERDICT

The 29% Earnings Collapse That Volume Growth Can't Hide

CNG volumes delivered a strong 9.1% year-on-year beat to guidance, but net profit collapsed 29% as LNG cost volatility, the new HPPHIT formula, and industrial weakness overwhelmed the top-line. Management's tone shifted from confident to defensive.

Q2 FY27 resultsMGLMahanagar Gas Ltd06 Nov 2026 · 6 min read
Reported Revenue

₹2,778 Cr

+23.1% YoY

Reported PAT

₹135 Cr

−29.2% YoY

EBITDA (Q2)

₹287 Cr

−16.3% QoQ

CNG Volume

+9.1% YoY

Beat 8–9% guidance

Mahanagar Gas delivered a paradox. Volumes beat guidance — CNG surged 9.1% year-on-year to 3.55 MMSCMD, and domestic PNG grew 9.8%. Yet on the profit line, the company swung in the wrong direction. Net profit fell 29.2% to ₹135 Cr despite revenue climbing 23%. The culprit: LNG cost volatility, the live-now HPPHIT allocation formula erosion, and industrial segment collapse. What management came to the call to celebrate — volume momentum — has become a backdrop to a harder story: margin survival.

The ledger: revenue vs. margin

EBITDA from operations in Q2 was ₹287 Cr, down 16.3% from ₹343 Cr in Q1. H1 EBITDA sits at ₹630 Cr, down 24.9% from ₹839 Cr in the prior-year half. The company's operational profit margin compressed despite top-line expansion — a symptom of cost pass-through failure, not execution shortfall. Management pinned the blame on three structural headwinds: (1) LNG supplies constrained at 70–80% of base demand, forcing heavier hedging into term contracts; (2) the HPPHIT allocation formula now live (25% Nov–Dec, ramping to 100% by Jul 2027), which shifts allocation away from volume-based bidding and erodes pricing power for smaller players; and (3) industrial/commercial volumes down 7.5% year-on-year due to supply restriction and Brent-linked customer pricing pressure.

Management's claims vs. what the numbers say

CNG growth at 8–9% for FY27 guidance

What delivered

Delivered 9.14% YoY in Q2 (3.26 → 3.55 MMSCMD)

Verdict

Supported — beat guidance

Results better than market expectations; 9–10% volume growth

What delivered

Overall 6.49% volume growth; PAT -29.2% YoY

Verdict

Overstated — conflates CNG rate with company-level growth; PAT well below prior year

Industrial recovery will be double-digit when macro normalizes

What delivered

I&C down 7.5% YoY; no timeline or contingency on recovery

Verdict

Unverified — assertion without mechanism

EBITDA margin target INR8–9/scm long-term maintained

What delivered

Q2 unit margin ~₹6.77/scm vs ~₹7 prior quarter

Verdict

Slipping — short of target; no quarterly guidance given due to volatility

What changed on this call

  • HPPHIT formula now live; phases to 100% by Jul 2027, eroding pricing power for smaller CGDs (MGL is large, so relative benefit, but margin volatility spike admitted)

  • Industrial weakness now explicit as a supply/macro constraint, not temporary. I&C volumes -7.5% YoY; recovery claimed but no timeline

  • CNG growth beat guidance at +9.1% YoY; domestic segment +9.5% and small commercial +12% offset I&C decline

  • Capex guidance reaffirmed at ₹1,500–1,800 Cr for FY27; FCF negative ₹200–300 Cr acknowledged. Funded by ~₹1,000 Cr balance sheet surplus; no debt planned

The bull-bear ledger

  • CNG volume momentum is real: +9.1% YoY beats 8–9% FY27 guidance; domestic and small-commercial pulling growth

  • PNG Drive 3.0 capex is credible: ₹1,500–1,800 Cr FY27 investment locked; 70.5k DPNG conversions added Q2; 2.24M cumulative by Sep 30

  • Balance sheet strong: ~₹1,000 Cr surplus funds capex without debt. Promoter holding stable at 32.5%

  • PAT down 29.2% YoY despite 23% revenue growth; earnings quality deteriorated from cost pass-through failure

  • Industrial segment down 7.5% YoY; supply-constrained at 70–80% of base. Recovery 'double-digit' claim lacks timeline or contingency

  • HPPHIT formula phase-in (Nov 2026 → Jul 2027) is structural headwind. Unit margin already slipped to ₹6.77/scm from ₹7 prior quarter

  • LNG supply constrained & cost hedging partial. 70–80% of base available; Brent volatility uncontrolled

  • FCF negative ₹200–300 Cr FY27 due to capex intensity. Dependent on balance sheet surplus; no margin for upside capex surprises

Risks, ranked by how much they should concern a holder

Margin volatility & cost pass-through failure

High

PAT down 29% YoY despite 23% revenue growth. EBITDA Q2 ₹287 Cr vs Q1 ₹343 Cr (−16% QoQ). LNG spot/term mix, Brent-linked pricing, and HPPHIT formula now live are eroding unit margins. Management hedging via term contracts only partial; no quarterly guidance given ('very difficult to predict').

Industrial segment weakness persists if macro doesn't normalize

Medium

I&C down 7.5% YoY due to supply restriction (70–80% of base) and Brent impact. Management claims 'double-digit' recovery but no timeline, no contingency. If Hormuz tensions or Brent remain elevated, I&C could stay pressured into H2 FY27.

HPPHIT allocation formula phase-in erodes pricing power

Medium

Formula ramps from 25% (Nov–Dec 2026) to 100% (Jul 2027), shifting allocation from volume-based bidding to consumption-based. MGL is a large player (benefits) but smaller CGD competitors lose allocation, triggering potential consolidation or margin warfare. Long-term pricing power uncertain.

Capex intensity & FCF burn dependency on balance sheet

Medium

FY27 capex ₹1,500–1,800 Cr will generate FCF negative ₹200–300 Cr. No debt planned; relying on ~₹1,000 Cr surplus. If capex overruns or inflation pressures costs, or if cash generation disappoints, balance sheet covenant risk emerges.

Geopolitical LNG supply disruption (Hormuz Strait)

Medium

Cited as ongoing headwind by management. Global LNG supply constrained; India LNG imports recovering but fragile. MGL sources 40% via LNG (rest 60% domestic APM). Term contracts hedge single-source risk, but if supply shock occurs, unit economics degrade further.

How the street is positioned

The stock trades at ₹1,106 (as of Nov 5, 2026) in a neutral trend, above its 20-day (₹1,046), 50-day (₹1,063), and 200-day (₹1,089) simple moving averages. RSI sits at 65.8 — overbought territory, but not decisively so. The 52-week range is ₹900–₹1,286; the stock is down 44.4% from its all-time high of ₹1,988, suggesting significant drawdown from euphoria. Yet it's recovered 22.9% off the low, indicating some institutional re-entry. Volume trend is increasing, a sign of active repricing.

Ownership data shows FII trimming. FII holding fell to 23.21% in Q1 FY27 (from 24.14% in Q4 FY26), a 93 basis point drop. DII, conversely, added 152 basis points to 22.53%. Promoter holding remains stable at 32.5%. The FII pullback is subtle but real — foreign institutions are cautiously exiting, not fleeing. The DII addition suggests domestic institutions view the pullback as an entry point or a value play, but at subdued conviction levels.

Reconciling this against fundamentals: the stock is pricing in a recovery narrative (hence the move off the low), but investors are also hedging near-term margin uncertainty (hence FII reducing). The neutral RSI and stable moving averages suggest the market is waiting for either a catalyst (I&C recovery, Brent normalization) or a deterioration (more capex acceleration, balance sheet stress). The 44% drawdown from ATH is a warning against chasing euphoria, but it's also not so deep that it screams capitulation. The honest read: the market is unsure, and so are institutions.

The debate

What to watch next

  • 1 · Q3 & Q4 industrial recovery pace

    The key resolution variable. If I&C volumes stabilize or rebound as Brent/supply normalize, the bear case weakens. If I&C stays flat or declines, margin pressure persists into FY28. Management's claim of 'double-digit' recovery has no timeline; watch for any guidance update.

  • 2 · HPPHIT formula phase-in impact (Nov 2026 → Jul 2027)

    Watch management commentary on allocation received and pricing realized in Q3 (November data) and Q4 (December–January). If MGL's allocation holds or grows despite formula shift, the company is positioned well. If it shrinks, smaller competitors are hollowing out the base.

  • 3 · FCF and capex execution

    FY27 capex run-rate is critical. Q1 was only ₹350 Cr (seasonal low), so Q2–Q4 will accelerate. Watch for any scope expansion, cost inflation, or delays. If capex stays in the ₹1,500–1,800 Cr band and balance sheet surplus cushions the burn, confidence holds. If capex blows out, balance sheet erodes fast.

The number to track from here

Forget reported PAT for now. Track unit EBITDA margin (₹/scm). Q2 came in at ₹6.77/scm vs ₹7.00 prior quarter — a 3.3% sequential decline. Management's long-term target is ₹8–9/scm. If Q3 holds ₹6.77 or higher, the trajectory is stable. If it slips below ₹6.50, the margin trap is real and structural. This single metric tells you whether LNG hedging, HPPHIT formula management, and I&C pricing are working or not.

Mahanagar Gas is a steady, well-executed infrastructure play with structural volume tailwinds. The CNG business is growing at the right speed, PNG Drive 3.0 capex is credible, and the balance sheet is strong. But this quarter revealed that earnings durability is hostage to cost factors outside management's full control — LNG pricing, Brent moves, HPPHIT formula changes, and industrial customer demand elasticity. The 29% PAT collapse is the real news; volume growth is just backdrop. Hold the position on the thesis that volume will sustain 8–10% and capex will unlock long-term value, but do not buy on the assumption that margins will quickly recover. Wait for either I&C stabilization or a clearer margin trajectory before upgrading. The stock has repriced 44% from its high, and institutions are hedging — a signal to stay patient and selective.

Informational and educational content only. Not investment advice.